Please select the option that best describes you:

How do you approach balancing the potential risk of worsening actinic damage and maintaining CTCL clearance in patients treated with nb-UVB?  



Answer from: at Academic Institution
Sign in or Register to read more

Answer from: at Community Practice
Sign in or Register to read more